These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11365805)
21. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
22. Salvage therapy for Indinavir and Ritonavir users. TreatmentUpdate; 1999 Jul; 11(5):1-2. PubMed ID: 11366926 [TBL] [Abstract][Full Text] [Related]
23. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005). Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange J; Cooper DA; Phanuphak P Antivir Ther; 2006; 11(2):223-32. PubMed ID: 16640103 [TBL] [Abstract][Full Text] [Related]
24. Merck pushes the envelope with once-daily indinavir. TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096 [No Abstract] [Full Text] [Related]
32. Evaluation of simplified protease inhibitor dosing regimens for the treatment of HIV infection. Cohen CJ; Hellinger J; Norris D AIDS Read; 2000 May; 10(5):296-9, 304-7, 311-3. PubMed ID: 10851721 [TBL] [Abstract][Full Text] [Related]
33. Different combinations of ritonavir-indinavir. TreatmentUpdate; 2001 Sep; 13(5):1-2. PubMed ID: 11768859 [No Abstract] [Full Text] [Related]
34. Pharmacokinetic study of the variability of indinavir drug levels when boosted with ritonavir in HIV-infected children. Curras V; Hocht C; Mangano A; Niselman V; Mariño Hernández E; Cáceres Guido P; Mecikovsky D; Bellusci C; Bologna R; Sen L; Rubio MC; Bramuglia GF Pharmacology; 2009; 83(1):59-66. PubMed ID: 19052483 [TBL] [Abstract][Full Text] [Related]
35. Antiviral therapy: how simple can you get? Gilden D GMHC Treat Issues; 1998 Nov; 12(11):3-7. PubMed ID: 11365906 [TBL] [Abstract][Full Text] [Related]
36. Twice-daily dosing of Nelfinavir approved. Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366888 [TBL] [Abstract][Full Text] [Related]
37. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study). Burger DM; Aarnoutse RE; Dieleman JP; Gyssens IC; Nouwen J; de Marie S; Koopmans PP; Stek M; van der Ende ME Antivir Ther; 2003 Oct; 8(5):455-61. PubMed ID: 14640393 [TBL] [Abstract][Full Text] [Related]
38. Protease inhibitors at a glance... Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198 [TBL] [Abstract][Full Text] [Related]
39. Protease inhibitor drug combinations. Baker R BETA; 1998 Apr; ():7. PubMed ID: 11365274 [TBL] [Abstract][Full Text] [Related]
40. Ritonavir and indinavir one year later. TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]